宏達股份(600331.SH):公司業務受本輪美國政府加徵“對等關税”政策的直接影響較小
格隆匯4月8日丨宏達股份(600331.SH)在投資者互動平台表示,公司主營業務為磷化工、有色金屬鋅冶煉,主要產品為鋅錠及其合金產品、磷酸一銨、複合肥。目前公司生產的所有產品銷售收入均來自國內,產品未出口美國;主要原材料購入方大部分來自國內,其中磷礦石、煤炭、天然氣均來自於國內,鋅精礦少部分來自於祕魯和哈薩克斯坦,未從美國進口。經評估,公司業務受本輪美國政府加徵“對等關税”政策的直接影響較小。公司將持續關注相關政策動態,積極應對市場變化,加快技術創新,增強產品盈利能力,以提升自身的競爭力和抗風險能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.